SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-035563
Filing Date
2023-06-08
Accepted
2023-06-08 18:14:59
Documents
2
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4043
2 POA DOCUMENT poa.txt EX-24 3051
  Complete submission text file 0001209191-23-035563.txt   8485
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Issuer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EXICURE, INC. 8045 LAMON AVENUE, SUITE 410 SKOKIE IL 60077
Business Address
Muralidhar Bali (Reporting) CIK: 0001784138 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40315 | Film No.: 231003289